These findings indicate an interaction between CDK5 signaling and tumor stromal cells, which may underlie the novel epigenetic mechanism of tumor environment-induced metastasis and hold therapeutic potential in breast cancer. This evidence concerns the gene CDK5 and breast carcinoma.